MyFinsight
Home
Blog
About
Short-term marketable
securities
$508,941K
(-32.83%↓ Y/Y)
Cash and cash
equivalents
$201,530K
(42.72%↑ Y/Y)
Prepaid expenses and
other current assets
$35,390K
(-1.02%↓ Y/Y)
Inventory
$4,139K
Accounts receivable, net
$3,927K
Total current assets
$753,927K
(-19.34%↓ Y/Y)
Long-term marketable
securities
$229,534K
(192.54%↑ Y/Y)
Property and equipment,
net
$49,926K
(-14.97%↓ Y/Y)
Finance lease
right-of-use asset
$46,700K
(-7.27%↓ Y/Y)
Intangible asset, net
$35,250K
Other non-current
assets
$25,825K
(12.43%↑ Y/Y)
Operating lease
right-of-use asset
$16,793K
(-20.12%↓ Y/Y)
Total assets
$1,157,955K
(-0.71%↓ Y/Y)
Total liabilities and
stockholders equity
$1,157,955K
(-0.71%↓ Y/Y)
Total stockholders'
equity
$835,178K
(-18.68%↓ Y/Y)
Total liabilities
$322,777K
(131.90%↑ Y/Y)
Accumulated deficit
-$2,307,524K
(-28.48%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$1,969K
(-309.69%↓ Y/Y)
Additional paid-in capital
$3,142,747K
(11.43%↑ Y/Y)
Liability related to the
revenue participation...
$205,189K
Total current
liabilities
$90,083K
(-1.07%↓ Y/Y)
Operating lease
liability, less current...
$22,026K
(-31.40%↓ Y/Y)
Finance lease
liability, less current...
$5,479K
(-1.76%↓ Y/Y)
Common stock, 0.01 par
value 400,000,000...
$1,924K
(7.91%↑ Y/Y)
Other accrued costs
and current...
$78,276K
(1017.27%↑ Y/Y)
Accounts payable
$11,807K
(8.88%↑ Y/Y)
Back
Back
Balance Sheet
Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI)
source: myfinsight.com